title: Is British Biotech's Marimastat a major cancer drug?
authors.forename: S
authors.initials: S
authors.lastname: Davidson
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004345:Drug Industry; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D007449:Investments; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D009361:Neoplasm Invasiveness; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000473:pathology; D006113:United Kingdom
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D006877:Hydroxamic Acids; C100342:marimastat; D008666:Metalloendopeptidases